CEO and Chairman Quang Pham Sells Shares in Cadrenal Therapeutics

Quang Pham, the CEO and Chairman of Cadrenal Therapeutics, Inc., sold shares of the company's common stock on October 24 and October 27, 2025, under a Rule 10b5-1 trading arrangement. The transactions involved the sale of 1,129 shares at a weighted average price of $14.03 and 1,315 shares at a weighted average price of $13.99. Following these transactions, Pham's direct ownership decreased to 196,089 shares. Additionally, Pham holds 200,000 shares indirectly through The PVBQ Living Trust, where he serves as the trustee with sole voting and disposition power. The sales were part of a pre-arranged trading plan, and the prices reported are weighted averages with the actual prices ranging from $13.99 to $14.10.